Skip to main content
Equibles

MARSHALL WACE, LLP

Position in ALVO — Alvotech

CIK 1318757 LONDON, X0
Back to ALVO Full portfolio

Position in ALVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$264,896
-$855,979 QoQ
Shares Held
71,788
-47.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 72 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALVO Over Time

Shares Held

Position Value (USD)

Derivatives in ALVO

reported options exposure · as of Sep 30, 2022
CallValue
$0
CallShares
68,413
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. ALVO ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 4,217,767 $146,229,981
2 ELAN
Elanco Animal Health Inc
 4,432,350 $109,080,132
3 LNTH
Lantheus Holdings, Inc.
 773,978 $85,865,119
4 ALKS
Alkermes plc.
 969,954 $50,825,589
5 NBIX
Neurocrine Biosciences Inc
 270,754 $45,632,878
6 RDY
Dr Reddys Laboratories Ltd
 2,025,356 $29,347,408
7 AMPH
Amphastar Pharmaceuticals, Inc.
 1,066,322 $21,518,377
8 ZTS
Zoetis Inc.
 257,470 $18,501,794

All Filings in ALVO

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $264,896 71,788
2025-09-30 $1,120,875 136,859
2024-09-30 $395,234 33,213
2024-06-30 $474,142 38,992
2024-03-31 $3,056,503 250,123